| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |